Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Ambrosini

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Endocrinology|March 15, 2021
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine ChemotherapySalvatore Grisanti, Deborah Cosentini, Marta Laganà, et al.
Cancers|June 3, 2020
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple CriteriaRoberta Ambrosini, Maria Carolina Balli, Marta Laganà, et al.
Cancers|September 28, 2023
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance StatusAntonella Turla, Marta Laganà, Andrea Abate, et al.
Cancers|April 16, 2020
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia ExperienceMarta Laganà, Salvatore Grisanti, Deborah Cosentini, et al.
European Journal of Endocrinology|January 14, 2026
Chemo-immunotherapy with cisplatin and nivolumab as second line approach in metastatic adrenocortical carcinomaMarta Laganà, Sara Rodella, Davide Lorenzo Bettini, et al.
Diagnostics (Basel, Switzerland)|June 24, 2022
Different Lung Parenchyma Quantification Using Dissimilar Segmentation Software: A Multi-Center Study for COVID-19 PatientsCamilla Risoli, Marco Nicolò, Davide Colombi, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Endocrinology|March 15, 2021
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine ChemotherapySalvatore Grisanti, Deborah Cosentini, Marta Laganà, et al.
Cancers|June 3, 2020
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple CriteriaRoberta Ambrosini, Maria Carolina Balli, Marta Laganà, et al.
Cancers|September 28, 2023
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance StatusAntonella Turla, Marta Laganà, Andrea Abate, et al.
Cancers|April 16, 2020
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia ExperienceMarta Laganà, Salvatore Grisanti, Deborah Cosentini, et al.
European Journal of Endocrinology|January 14, 2026
Chemo-immunotherapy with cisplatin and nivolumab as second line approach in metastatic adrenocortical carcinomaMarta Laganà, Sara Rodella, Davide Lorenzo Bettini, et al.
Diagnostics (Basel, Switzerland)|June 24, 2022
Different Lung Parenchyma Quantification Using Dissimilar Segmentation Software: A Multi-Center Study for COVID-19 PatientsCamilla Risoli, Marco Nicolò, Davide Colombi, et al.
Pageof 2